Advances in Murine Models for Metabolic Diseases: Insights into Diabetes, Obesity, and Cardiovascular Conditions

A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Nutrition and Metabolism".

Deadline for manuscript submissions: 1 July 2025 | Viewed by 721

Special Issue Editor


E-Mail Website
Guest Editor
Laboratory of Metabolomic and Chronic Degenerative Diseases, Physiology Institute, Meritorious Autonomous University of Puebla, Puebla C.P. 72560, Mexico
Interests: metabolic diseases; chronic degenerative diseases; endocrinology; inflammation; oxidative stress; biochemistry; molecular biology

Special Issue Information

Dear Colleagues,

Advances in murine models are crucial for understanding the complex interplay of metabolic diseases like diabetes, obesity, and cardiovascular conditions. This Special Issue of Metabolites focuses on cutting-edge research utilizing these models to dissect disease mechanisms and identify potential therapeutic targets.

Focus: This Special Issue emphasizes innovative approaches in the murine modeling of metabolic diseases. This includes genetically modified mice (e.g., knockouts, knock-ins, and transgenics), diet-induced models (e.g., high-fat diet and high-fructose diet), and combined approaches that mimic the multifaceted nature of human diseases. We also encourage submissions exploring the impact of gut microbiota, inflammation, and other contributing factors on metabolic dysfunction in these models.

Scope: This Special Issue covers a broad spectrum of research areas, including the following:

  • Mechanistic studies investigating the molecular pathways involved in disease development and progression.
  • Preclinical testing of novel therapeutic interventions, including pharmacological agents, dietary interventions, and gene therapies.
  • Studies exploring the link between metabolic disorders and related complications, such as cardiovascular disease, neuropathy, and nephropathy.
  • Development and validation of new techniques for assessing metabolic phenotypes in mice, including metabolomics, imaging, and physiological measurements.

Purpose: This Special Issue aims at providing a comprehensive overview of the current state of the art in murine models of metabolic diseases. It serves as a valuable resource for researchers in the field, facilitating the exchange of knowledge and fostering collaborations. By highlighting recent advances and identifying knowledge gaps, this Special Issue will guide future research and accelerate the development of effective strategies for preventing and treating human metabolic disorders.

Prof. Dr. Samuel Treviño
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • murine models
  • metabolic diseases
  • molecular mechanisms
  • biochemical pathways
  • pharmacological strategies
  • interactome
  • comorbidities
  • metabolic phenotypes
  • novel techniques

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

32 pages, 5153 KiB  
Article
Naringenin Decreases Retroperitoneal Adiposity and Improves Metabolic Parameters in a Rat Model of Western Diet-Induced Obesity
by Gabriela López-Almada, J. Abraham Domínguez-Avila, Rosario Maribel Robles-Sánchez, Jonathan Arauz-Cabrera, Gustavo Martínez-Coronilla, Gustavo A. González-Aguilar and Norma Julieta Salazar-López
Metabolites 2025, 15(2), 109; https://doi.org/10.3390/metabo15020109 - 8 Feb 2025
Viewed by 554
Abstract
Background: Obesity is a multifactorial disease with detrimental effects on health and quality of life; unregulated satiety plays a crucial role in food intake and obesity development. Naringenin (NAR) has shown beneficial effects on lipid and carbohydrate metabolism, although its impact on adiposity [...] Read more.
Background: Obesity is a multifactorial disease with detrimental effects on health and quality of life; unregulated satiety plays a crucial role in food intake and obesity development. Naringenin (NAR) has shown beneficial effects on lipid and carbohydrate metabolism, although its impact on adiposity and satiety remains unclear. This study reports a Western diet (WD)-induced obesity model in rats, wherein 100 mg/kg of NAR was administered as an anti-obesity agent for 8 weeks; oxidative stress, lipid profile, and satiety biomarkers were then studied, as well as in silico interaction between NAR and cholecystokinin (CCK) and ghrelin receptors. Results: NAR supplementation resulted in a significant decrease in retroperitoneal adipose tissue and liver weight, as compared to the untreated WD group (p < 0.05), potentially associated with a decreased feed efficiency. NAR also inhibited the development of dyslipidemia, particularly by reducing serum triglycerides (p < 0.05). NAR supplementation increased CCK serum levels in the basal diet group, an effect that was abolished by the WD (p < 0.05); likewise, no changes were determined on ghrelin (p > 0.05). In silico data shows that NAR is capable of interacting with the CCK and ghrelin receptors, which suggests a potential for it to modulate hunger/satiety signaling by interacting with them. Conclusions: We conclude that NAR has anti-obesogenic effects and may regulate CCK serum levels, although further research is still needed. Full article
Show Figures

Graphical abstract

Back to TopTop